Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include sometimes findings: Weak and brittle bones (osteoporosis). 9 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 2 | Abnormal bleeding tendency (abnormal bleeding), Low platelet count (thrombocytopenia) |
SRC function has not been fully characterized.
Thrombocytopenia 6 has been associated with mutations in the SRC gene on chromosome 20.
Genetic testing for SRC is available. Testing is considered supportive for diagnosis.
Biomarker and diagnostic research for thrombocytopenia 6 has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for thrombocytopenia 6.
165 publications have been identified in PubMed for thrombocytopenia 6. Research spans Clinical Trial Publication (28%), Epidemiology / Natural History (20%), and Review / Meta-Analysis (18%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 46 | 28% |
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 5:35 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
2 |
Weak and brittle bones (osteoporosis), Bone marrow hypercellularity |
33 |
20% |
Research summaries | 30 | 18% |
Patient case studies | 22 | 13% |
Laboratory research | 21 | 13% |
Testing and diagnosis research | 8 | 5% |
New treatment approaches | 4 | 2% |
Other research | 1 | 1% |
Jin Y (2026). [PMID: 42164499](https://pubmed.ncbi.nlm.nih.gov/42164499/). *Front Immunol*. [Review / Meta-Analysis]
Ding Y (2026). [PMID: 41899415](https://pubmed.ncbi.nlm.nih.gov/41899415/). *Current issues in molecular biology*. [Review / Meta-Analysis]
Takahashi S (2026). [PMID: 42069215](https://pubmed.ncbi.nlm.nih.gov/42069215/). *J Infect Chemother*. [Review / Meta-Analysis]
Smith MA (2026). [PMID: 41248753](https://pubmed.ncbi.nlm.nih.gov/41248753/). *Transplant Cell Ther*. [Diagnostic / Biomarker]
Kamarádová K (2026). [PMID: 41996258](https://pubmed.ncbi.nlm.nih.gov/41996258/). *Cesk Patol*. [Review / Meta-Analysis]
Joly BS (2026). [PMID: 40875883](https://pubmed.ncbi.nlm.nih.gov/40875883/). *Blood advances*. [Epidemiology / Natural History]
Roh D (2026). [PMID: 41891705](https://pubmed.ncbi.nlm.nih.gov/41891705/). *Neurosurgery*. [Epidemiology / Natural History]
Wang H (2026). [PMID: 42057816](https://pubmed.ncbi.nlm.nih.gov/42057816/). *Front Oncol*. [Clinical Trial Publication]
Mahé I (2026). [PMID: 41365312](https://pubmed.ncbi.nlm.nih.gov/41365312/). *The Lancet. Haematology*. [Clinical Trial Publication]
Rousseau Z (2026). [PMID: 42055323](https://pubmed.ncbi.nlm.nih.gov/42055323/). *J Biol Chem*. [Basic Science / Preclinical]